500257 announcements Lupin Ltd. announcements and dividends declared BSE
Lupin Ltd. Complete list of announcements declared & dividend announcements by Lupin Ltd. 500257
Lupin Ltd. 500257 listed on BSE and deals inAnnouncements and dividends declared by Lupin Ltd. 500257
Lupin launches generic Sugammadex injection in US
Lupin Limited announced the launch of its Sugammadex Injection in the United States. This follows approval from the US Food and Drug Administration for its abbreviated new drug application. The company's injection is claimed to be bioequivalent to Merck's
Announcement as on 31 July 2026
Lupin launches generic anti-diabetic tablets in US
Pharma major Lupin has launched its generic anti-diabetic medicine in the United States. The medicine is dapagliflozin and metformin hydrochloride extended-release tablets. The US Food and Drug Administration approved the drug. Lupin's product is bioequiva
Announcement as on 22 April 2026
Zydus, Lupin sign pact to co-market weight-loss Semaglutide injection in India
Zydus Lifesciences and Lupin have joined forces to bring Semaglutide Injection to India. This medication helps manage type 2 diabetes and aids in chronic weight management. This collaboration aims to provide advanced therapies for metabolic disorders acros
Announcement as on 17 March 2026
Zydus partners with Lupin to co-market generic semaglutide in India
Zydus Lifesciences and Lupin are joining forces. They will make a generic version of the popular weight-loss and diabetes drug semaglutide more accessible in India. This collaboration follows the upcoming expiry of Novo Nordisk's patent. Lupin will co-mark
Announcement as on 17 March 2026
Lupin receives USFDA EIR for Goa facility with VAI status
Drug maker Lupin said it has received an Establishment Inspection Report from the US Food and Drug Administration for its Goa-based manufacturing facility, with a Voluntary Action Indicated classification following a November 2025 inspection.
Announcement as on 27 February 2026
Announcements by Lupin Ltd. first page | Next page |
500257 Lupin Ltd. current price & indicator signals
Recent prices of 500257 Lupin Ltd. are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 31 Fri Jul 2026 | 2413.95 | 2405.00 to 2433.70 | -0.21% | 0.72 times |
| 30 Thu Jul 2026 | 2419.10 | 2415.00 to 2475.00 | -1.25% | 1.39 times |
| 29 Wed Jul 2026 | 2449.80 | 2401.70 to 2463.00 | 2.3% | 2.64 times |
| 28 Tue Jul 2026 | 2394.70 | 2384.40 to 2423.90 | -0.63% | 0.11 times |
| 27 Mon Jul 2026 | 2409.90 | 2371.00 to 2431.85 | 1.71% | 0.38 times |
| 24 Fri Jul 2026 | 2369.45 | 2340.60 to 2385.90 | -1.11% | 0.25 times |
| 23 Thu Jul 2026 | 2396.00 | 2379.55 to 2428.85 | -0.41% | 0.46 times |
| 22 Wed Jul 2026 | 2405.80 | 2404.00 to 2498.90 | -4.32% | 0.53 times |
| 21 Tue Jul 2026 | 2514.40 | 2476.35 to 2521.40 | 1.46% | 0.45 times |
| 20 Mon Jul 2026 | 2478.30 | 2450.05 to 2493.00 | 1.48% | 0.42 times |
| 17 Fri Jul 2026 | 2442.10 | 2428.65 to 2498.80 | -2.32% | 3.37 times |
| 16 Thu Jul 2026 | 2500.05 | 2495.50 to 2530.00 | 0.33% | 0.22 times |
Videos related to: 500257 announcements Lupin Ltd. announcements and dividends declared BSE
Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra
Hindi Video What Is Needed To Succeed In Stock Markets
- BSE Screeners
- BSE Daily Screener
- BSE Weekly Screener
- BSE Monthly Screener
- Support & Resistance
- BSE Shares Near Support
- BSE Shares Near Resistance


